[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

Search:


View post   

>> No.23150798 [View]
File: 2.88 MB, 2380x2224, 1565871757962.png [View same] [iqdb] [saucenao] [google]
23150798

I came across this company called Eyenovia.
>Developing an atropine solution to myopia
They're not the only one but only one to be public. Currently no treatment for myopia exists but atropine is a common treatment in Asia and Europe, however no FDA approved solutions exist in US.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347209/

The company financials look bad but they recently made a deal with Artic vision that includes royalties and upfront payments which should give them enough gas till Q1 2021. Also, AV will buy MicroPine and Microline products from EYEN, both of which are a in the drug pipeline.

What does /smg/ think? It's a multibillion dollar market in US alone and marketcap is only 50 million. I'm hoping they'd be the first to get FDA approval for their solution and special dosing equipment.

https://youtu.be/TVTnwSAFNsQ

Navigation
View posts[+24][+48][+96]